These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 20374430
1. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. Li Y, Tweedie D, Mattson MP, Holloway HW, Greig NH. J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430 [Abstract] [Full Text] [Related]
2. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T. Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [Abstract] [Full Text] [Related]
3. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice. Li Y, Bader M, Tamargo I, Rubovitch V, Tweedie D, Pick CG, Greig NH. J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185 [Abstract] [Full Text] [Related]
4. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH. Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207 [Abstract] [Full Text] [Related]
5. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4. Mann RJ, Nasr NE, Sinfield JK, Paci E, Donnelly D. Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595 [Abstract] [Full Text] [Related]
6. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. Li Y, Wu KJ, Yu SJ, Tamargo IA, Wang Y, Greig NH. Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285 [Abstract] [Full Text] [Related]
8. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration. Kopp KO, Li Y, Glotfelty EJ, Tweedie D, Greig NH. Biomolecules; 2024 Jul 19; 14(7):. PubMed ID: 39062586 [Abstract] [Full Text] [Related]
11. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Xie Z, Enkhjargal B, Wu L, Zhou K, Sun C, Hu X, Gospodarev V, Tang J, You C, Zhang JH. Neuropharmacology; 2018 Jan 19; 128():142-151. PubMed ID: 28986282 [Abstract] [Full Text] [Related]
15. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Gastroenterology; 2004 Aug 03; 127(2):546-58. PubMed ID: 15300587 [Abstract] [Full Text] [Related]
16. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M. Endocrinology; 2010 Apr 03; 151(4):1520-31. PubMed ID: 20172966 [Abstract] [Full Text] [Related]
18. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes. Mangmool S, Hemplueksa P, Parichatikanond W, Chattipakorn N. Mol Endocrinol; 2015 Apr 03; 29(4):583-96. PubMed ID: 25719403 [Abstract] [Full Text] [Related]
19. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W. Mol Vis; 2014 Apr 03; 20():1557-68. PubMed ID: 25489228 [Abstract] [Full Text] [Related]
20. Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity. Kim JY, Lim DM, Moon CI, Jo KJ, Lee SK, Baik HW, Lee KH, Lee KW, Park KY, Kim BJ. J Korean Med Sci; 2010 Nov 03; 25(11):1626-32. PubMed ID: 21060752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]